An interventional study of Questionnar in Diabetes, sponsored by University Hospital, Grenoble. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-05-05.
Sponsored by University Hospital, Grenoble · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 352 studies in Diabetes Mellitus with a site in France — 47 open to participants now, 53 under way, 3 of them phase 3. Diabetes Mellitus · France.
Among the 352 studies in Diabetes Mellitus with a site in France, this one is the 38th largest by planned enrollment of the 242 interventional ones that give a count, is one of 11 that started in 2026, is one of 100 with no phase, reaches primary completion later than 20 of the 51 other live ones, and was the 346th registered.
8,295 studies on the registry are indexed under Diabetes Mellitus; 1,071 are open to participants now.
Browse Diabetes Mellitus studies →47 of the 352 studies in Diabetes Mellitus with a site in France are open now. Recruiting first, the newest first:
Nantes University Hospital · Sites in France
Ages 18–80
Pfizer · Sites in France, United States, Brazil and 8 more countries
Ages 18+
Centre Hospitalier Sud Francilien · Sites in France
Ages 18+
Insulet Corporation · Sites in France
Ages 2+
Solsius · Sites in France
Ages 18+
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 649 Diabetes Mellitus studies recruiting now, 358 (55%) set no upper age limit and 194 (30%) stop at 75 or younger; 89 take children under 18; 181 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
352 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 6 · Phase 2 32 · Phase 3 83 · Phase 4 27
First in 1990; this study’s year is marked. 11 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 900 is above the median of 80 across 6,027 interventional studies indexed under Diabetes Mellitus.
Median enrollment 187 across the 242 interventional studies, 268 across the 110 observational. Of the 263 that completed or were terminated, 71 (27%) have results posted.
This tab as a report to print or save as PDF → With an account.
144 of 352 have an industry lead sponsor. The 10 most frequent:
University Hospital, Grenoble is the lead sponsor of 838 studies on the registry; 208 are open to participants now.
University Hospital, Grenoble has 4 studies filed under Diabetes Mellitus — fewer than ten, so there is no comparison to draw.
13 of the studies in Diabetes Mellitus with a site in France that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07455994Centre Hospitalier Universitaire de Saint EtienneDysautonomia in Children With Type 1 Diabetes | 2026-12 |
| NCT05795582Centre Hospitalier Universitaire de NiceUpstroke Time Measured by Photoplethysmography | 2026-12-14 |
| NCT06782997CHU de ReimsPerformance of the Electroretinogram, Performed and Interpreted by an Advanced Practice Nurse, in the Screening for Diabetic Retinopathy. | 2026-12-17 |
| NCT06066801Assistance Publique - Hôpitaux de ParisBedside Bone Biopsy in Diabetic Foot Osteomyelitis | 2027-03 |
| NCT07910721SolsiusContinuous Monitoring of Plantar Temperature Variations Using Connected Insoles and a Mobile Application for Diabetic Foot. | 2027-04-10 |
Add all 13 to your calendar (.ics) → With an account.
Among the 352 studies in Diabetes Mellitus with a site in France, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The BF-ACT study is a single-center, non-interventional (RIPH3) descriptive study conducted at CHU Grenoble Alpes. It aims to evaluate the satisfaction of adults with type 1 diabetes using closed-loop insulin delivery systems, specifically regarding the "physical activity mode" designed to adapt insulin delivery during exercise.
Although physical activity is essential for managing type 1 diabetes, it remains challenging due to the risk of hypoglycemia. Closed-loop systems have improved glucose control, but their effectiveness during exercise depends on multiple factors, and their real-life use can be complex. Currently, little is known about patient satisfaction and experience with these specific modes.
The study will collect data through a self-administered questionnaire, distributed to eligible patients (≥18 years old, with type 1 diabetes, using a closed-loop system for at least 4 months). The primary outcome is the satisfaction score based on the questionnaire. Secondary objectives include describing physical activity perception, usage of the activity mode, and comparing users versus non-users.
Approximately up to 900 patients may be included over a 4-month recruitment period. Clinical and glucose monitoring data will also be collected from medical records. The results are expected to improve patient education, device usability, and support for physical activity in people living with type 1 diabetes.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion criteria
Other: Questionnar
Administration of 1 questionnar to investigate the satisfaction with the physical activity mode of closed-loop systems among people living with type 1 diabetes.
Satisfaction score
Part C, D and E of the questionnar
Time frame: Baseline
Describe the perception of physical activity within the study population
Part A of the questionnar
Time frame: Baseline
Describe the proportion of individuals using the physical activity mode in our study
Part B of the questionnar
Time frame: Baseline
Describe satisfaction with the mode in relation to the physical activities performed by patients
Part F of the questionnar
Time frame: Baseline
Describe overall satisfaction with the "physical activity" mode
Part G of the questionnar
Time frame: Baseline
Compare populations who use the physical activity mode with those who do not use it
Comparison based on several parameters to describe the two populations at the time of questionnaire completion: HbA1c (%)
Time frame: Baseline
Compare populations who use the physical activity mode with those who do not use it
Comparison based on several parameters to describe the two populations at the time of questionnaire completion: Type of closed-loop system
Time frame: Baseline
Compare populations who use the physical activity mode with those who do not use it
Comparison based on several parameters to describe the two populations at the time of questionnaire completion: Duration of use of the closed-loop system
Time frame: Baseline
Compare populations who use the physical activity mode with those who do not use it
Comparison based on several parameters to describe the two populations at the time of questionnaire completion: Time spent in closed-loop mode
Time frame: Baseline
Compare populations who use the physical activity mode with those who do not use it
Comparison based on several parameters to describe the two populations at the time of questionnaire completion: Duration of type 1 diabetes
Time frame: Baseline
Compare populations who use the physical activity mode with those who do not use it
Comparison based on several parameters to describe the two populations at the time of questionnaire completion: Age
Time frame: Baseline
Compare populations who use the physical activity mode with those who do not use it
Comparison based on several parameters to describe the two populations at the time of questionnaire completion: Sex
Time frame: Baseline
Compare populations who use the physical activity mode with those who do not use it
Comparison based on several parameters to describe the two populations at the time of questionnaire completion: Body Mass Index (BMI)
Time frame: Baseline
Compare populations who use the physical activity mode with those who do not use it
Comparison based on several parameters to describe the two populations at the time of questionnaire completion: CGM data over the 15 days prior to questionnaire completion: * Time in Range (TIR) 70-180 mg/dL * Time in Tight Range (TITR) 70-140 mg/dL * Time Above Range (TAR) \> 180 mg/dL and \> 250 mg/dL * Time Below Range (TBR) \< 70 mg/dL and \< 54 mg/dL
Time frame: Baseline
Compare populations who use the physical activity mode with those who do not use it
Comparison based on several parameters to describe the two populations at the time of questionnaire completion: CGM data over the 15 days prior to questionnaire completion: \- Mean glucose (mg/dL)
Time frame: Baseline
Compare populations who use the physical activity mode with those who do not use it
Comparison based on several parameters to describe the two populations at the time of questionnaire completion: CGM data over the 15 days prior to questionnaire completion: \- Glucose Management Index (GMI)
Time frame: Baseline
Compare populations who use the physical activity mode with those who do not use it
Comparison based on several parameters to describe the two populations at the time of questionnaire completion: CGM data over the 15 days prior to questionnaire completion: \- Coefficient of Variation (CV, in %)
Time frame: Baseline
Compare populations who use the physical activity mode with those who do not use it
Comparison based on several parameters to describe the two populations at the time of questionnaire completion: CGM data over the 15 days prior to questionnaire completion: \- Glycemia Risk Index (GRI)
Time frame: Baseline
Compare populations who use the physical activity mode with those who do not use it
Comparison based on several parameters to describe the two populations at the time of questionnaire completion: CGM data over the 15 days prior to questionnaire completion: \- Total daily insulin dose (IU/day)
Time frame: Baseline
Compare populations who use the physical activity mode with those who do not use it
Comparison based on several parameters to describe the two populations at the time of questionnaire completion: CGM data over the 15 days prior to questionnaire completion: \- Percentage of use of the physical activity mode
Time frame: Baseline
Plan to share: Undecided
No publications or documents are linked to this record.
Started Apr 2026 (actual). Primary completion is estimated for Aug 2026, 4 months after the start.
Of 1,590 non-industry interventional studies with no phase under Diabetes Mellitus, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's planned 4 months is below that.
Counting every sponsor, half of 1,750 studies reached it within 21 months; a quarter within 9 and three quarters within 42.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Grenoble →